← Evidence map

ReviewDer Pathologe2017

Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.

S AvrilPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29119232